search
1,127,752 Projects

  • 2014-2023

10
arrow_drop_down
  • Funder: WT Project Code: 089692
    Funder Contribution: 142,679 GBP
    more_vert
  • Funder: ARC Project Code: DP210102447
    more_vert
  • Funder: NHMRC Project Code: 2003019
    Funder Contribution: 768,757 $

    Progressive scarring, or fibrosis, of organs leads to their loss of function. Fibrotic diseases are devastating to both the individual and our community and we lack effective therapies. We have identified a small protein, named SPRF, which represents a new mechanism in tissue fibrosis. These studies will examine the role of the SRPF protein in models of kidney, heart and lung fibrosis and its underlying mechanism of action. We will also test a therapy based on inhibiting SPRF function.

    more_vert
  • Funder: NIH Project Code: 1R01AI120464-01
    Funder Contribution: 386,642 USD
    more_vert
  • Funder: NIH Project Code: 5R25GM055145-20
    Funder Contribution: 501,759 USD
    more_vert
  • Funder: NIH Project Code: 4R33AR073014-03
    Funder Contribution: 390,000 USD
    more_vert
  • Funder: NIH Project Code: 1K08CA245107-01
    Funder Contribution: 172,035 USD
    more_vert
  • Funder: NIH Project Code: 1R01HL111694-01A1
    Funder Contribution: 624,267 USD
    more_vert
  • Funder: NIH Project Code: 5R01DK055852-13
    Funder Contribution: 322,800 USD
    more_vert
  • Funder: NIH Project Code: 1R43AR077503-01
    Funder Contribution: 252,131 USD
    more_vert
1,127,752 Projects
  • Funder: WT Project Code: 089692
    Funder Contribution: 142,679 GBP
    more_vert
  • Funder: ARC Project Code: DP210102447
    more_vert
  • Funder: NHMRC Project Code: 2003019
    Funder Contribution: 768,757 $

    Progressive scarring, or fibrosis, of organs leads to their loss of function. Fibrotic diseases are devastating to both the individual and our community and we lack effective therapies. We have identified a small protein, named SPRF, which represents a new mechanism in tissue fibrosis. These studies will examine the role of the SRPF protein in models of kidney, heart and lung fibrosis and its underlying mechanism of action. We will also test a therapy based on inhibiting SPRF function.

    more_vert
  • Funder: NIH Project Code: 1R01AI120464-01
    Funder Contribution: 386,642 USD
    more_vert
  • Funder: NIH Project Code: 5R25GM055145-20
    Funder Contribution: 501,759 USD
    more_vert
  • Funder: NIH Project Code: 4R33AR073014-03
    Funder Contribution: 390,000 USD
    more_vert
  • Funder: NIH Project Code: 1K08CA245107-01
    Funder Contribution: 172,035 USD
    more_vert
  • Funder: NIH Project Code: 1R01HL111694-01A1
    Funder Contribution: 624,267 USD
    more_vert
  • Funder: NIH Project Code: 5R01DK055852-13
    Funder Contribution: 322,800 USD
    more_vert
  • Funder: NIH Project Code: 1R43AR077503-01
    Funder Contribution: 252,131 USD
    more_vert